Última Hora: "Tesla abre loja no Porto - Jornal de Negócios - Portugal" Fri, 21 Apr 2017 09:40:30 GMT   "DBRS mantém 'rating' de Portugal acima do nível lixo - TVI24" Fri, 21 Apr 2017 17:39:08 GMT    "American Airlines suspende hospedeira suspeita de agressão a passageira - Observador" Sat, 22 Apr 2017 21:30:58 GMT    "400 empresas testam novas tarifas da luz à la carte - Diário de Notícias - Lisboa" Sun, 23 Apr 2017 23:44:00 GMT    "Carro eléctrico voador que descola na vertical poderá ser o futuro dos transportes - Jornal de Negócios - Portugal" Sun, 23 Apr 2017 14:00:04 GMT    "eCooltra: O futuro de Lisboa em 170 motas elétricas - Notícias ao Minuto (liberação de imprensa)" Fri, 21 Apr 2017 08:04:48 GMT    "Recapitalização da CGD ?não contará para o défice? - Observador" Mon, 24 Apr 2017 00:53:00 GMT    "Banqueiros ficaram preocupados com Novo Banco - Observador" Sun, 23 Apr 2017 12:04:06 GMT    "Vender o ID ao preço do Golf. VW parte a loiça - Observador" Sun, 23 Apr 2017 12:16:07 GMT    "Americanos já são mais que os espanhóis nas Pousadas de Portugal - Expresso" Sun, 23 Apr 2017 20:00:45 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Procure análises técnicas no nosso fórum aqui: Análises Técnicas
Nota: Os dados após 2009-10-29 são ainda temporários e poderão por isso ter o valor de Abertura errado até nova actualização...
Mudar para Gráfico Estático de Sepracor Inc.

Activo não encontrado Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última TradeRange 52 Semanas[0,000 - 0,000]
Hora da Última TradeN/A - N/APrice-Target 1 AnoN/A
Variação ()Capitalização Bolsista3
Bid / AskN/AEPS0,00
AberturaPER12,69%
MáximoPagamento DividendoN/A
MínimoData Ex-DividendoN/A
Fecho Anterior0,000YieldN/A
VolumeVolume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)

Novelion Therapeutics Appoints Mark Corrigan, MD to Board of Directors
GlobeNewswire (press release)
Dr. Corrigan was previously president and chief executive officer of Zalicus Inc. Prior to that, he was executive vice president, research & development of Sepracor Inc. (now Sunovion Pharmaceuticals). Prior to joining Sepracor, Dr. Corrigan spent 10 ...

e mais »

ZIOPHARM Appoints Amy Trevvett Vice President of Investor ...
GlobeNewswire (press release)
BOSTON, March 27, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on new immunotherapies, ...

e mais »

Flex Pharma Names William K. McVicar, Ph.D. as President ...
Business Wire (press release)
Click to Tweet this News Flex Pharma, Inc. (NASDAQ: FLKS), focused on developing treatments for cramps and spasms associated with severe neurological.

e mais »

Biotech Losers in Spotlight: Flex Pharma, Inc. (NASDAQ:FLKS ...
Benchmark Monitor
Flex Pharma, Inc. (NASDAQ:FLKS) announced the appointment of William K. McVicar, Ph.D., as President of Research and Development. Dr. McVicar brings to ...

e mais »

InvestorGuide

Cynapsus Therapeutics (CYNA) Stock Doubles on Sunovion Buyout
InvestorGuide
Shares of Cynapsus Therapeutics Inc. (CYNA) were trading up +21.44 or +116.78 percent to $39.80 per share in Thursday's premarket after news broke late yesterday that it would be acquired by Sunovion Pharmaceuticals Inc. Cynapsus Therapeutics stock ...

e mais »

Worcester Telegram

Wall & Main: Marlboro's Sunovion shows growth potential
Worcester Telegram
For Marlboro-based Sunovion Pharmaceuticals, one of the languages is most certainly Japanese. That's because over six years ago, an Osaka, Japan-based pharmaceuticals company, Dainippon Sumitomo Pharma of Japan, acquired Marlboro's Sepracor ...


Frequency Therapeutics Announces its Board of Directors and the ...
Business Wire (press release)
Frequency Therapeutics debuts with announcement of Board of Directors; Lead program addresses chronic noise induced hearing loss.

e mais »

RXi Pharmaceuticals Enters into Exclusive Option Agreement to ...
PR Newswire (press release)
MARLBOROUGH, Mass., Oct. 12, 2016 /PRNewswire/ -- RXi Pharmaceuticals Enters into Exclusive Option Agreement to Acquire MirImmune Inc. Acquisition will ...

e mais »

Lisa Ricciardi to Join Board of Directors - Marketwired
Marketwired (press release)
YONKERS, NY--(Marketwired - February 15, 2017) - ContraFect Corporation ( NASDAQ : CFRX), a biotechnology company focused on the discovery and ...

e mais »

Sunovion Celebrates Five-Year Anniversary Milestone | Business Wire
Business Wire (press release)
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) announced today that it is celebrating its five-year anniversary.

e mais »

PMLiVE

Astellas appoints ethics and compliance and US legal leaders
PMLiVE
Wanda brings over 20 years of experience in the pharmaceutical industry, having held senior leadership positions at Schering-Plough and Sepracor Inc, a US-based biopharmaceutical company. Prior to joining Astellas as deputy general counsel and head of ...


TheChronicleHerald.ca (registration)

PEI's BioVectra buys former Sepracor plant in Windsor
TheChronicleHerald.ca (registration)
A Charlottetown drug manufacturer has acquired a mothballed Windsor pharmaceutical plant and plans to reopen the facility in early 2016. BioVectra Inc. purchased the former Sepracor Canada (Nova Scotia) Ltd. facility in May. The Sepracor operation ...
Charlottetown's BioVectra expanding, setting up in WindsorHants Journal

todos os 5 artigos de notícias »

RXi Pharmaceuticals Announces Closing of $11.5 Million ...
PR Newswire (press release)
MARLBOROUGH, Mass., Dec. 21, 2016 /PRNewswire/ -- RXi Pharmaceuticals Announces Closing of $11.5 Million Underwritten Public Offering and Full ...

e mais »

Adrian Adams named new CEO of Sepracor
Bizjournals.com
Before joining Sepracor, Adams had been the head of Kos Pharmaceuticals Inc., which was acquired in December by Abbott Laboratories for $3.7 billion. Adams' background includes research and development, sales, international and national product ...


POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
Business Wire (press release)
Prior to joining Sepracor, Mr. Adams was President and Chief Executive Officer of Kos Pharmaceuticals, Inc. until its acquisition by Abbott Laboratories. Mr. Adams has also held general management and senior international and national marketing ...

e mais »
Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc. 


Largura do Site:

 Imagem de Fundo:

Copyright@1998-2017 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters